Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides
- PMID: 2833568
- DOI: 10.1099/0022-1317-69-4-847
Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides
Abstract
The antibody response to herpes simplex virus (HSV) is complex and involves antibody to at least 33 virus-induced polypeptides. Serum IgG contains four isotypes in mice and it is known that the isotypes differ in their biological functions and that individual antigenic proteins may preferentially elicit restricted isotype responses. We therefore examined the anti-polypeptide isotypes induced in immune mouse serum. By ELISA, we found that the total serum virus-specific antibody activity was 51% IgG1, 39% IgG2a, 11% IgG2b and 1% IgG3 in immune ICR strain mice and 51%, 45%, 4% and 0.4% respectively in strain BALB/c mouse immune serum. These proportions are significantly different from those reported for other virus infections. Sepharose-Protein A affinity-purified isotypes were also studied and showed IgG1 greater than IgG2a greater than or equal to IgG2b much greater than IgG3 activity per microgram of isotype, indicating that competition between isotypes present in high concentrations did not significantly alter the results. Immunoblotting studies of the purified isotypes showed that the major immunogenic HSV-1 proteins (VP155, gC, gB, pgB, gD and nucleocapsid proteins 42K and 44K) induced all isotypes. However, the isotype responses were not uniform among the glycoproteins and some other proteins. In addition neutralization assays of the purified isotypes indicated that IgG2a and IgG2b had significantly greater neutralizing capacity than IgG1, suggesting that less of the IgG1 was directed against neutralizing virion epitopes. These data are discussed with respect to the biological implications in host defence.
Similar articles
-
Antibody activity to herpes simplex virus in mouse Ig classes and IgG subclasses.Arch Virol. 1988;98(3-4):225-33. doi: 10.1007/BF01322171. Arch Virol. 1988. PMID: 2831856
-
DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.DNA Cell Biol. 1999 Oct;18(10):771-9. doi: 10.1089/104454999314917. DNA Cell Biol. 1999. PMID: 10541436
-
The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies.J Gen Virol. 1989 Sep;70 ( Pt 9):2439-48. doi: 10.1099/0022-1317-70-9-2439. J Gen Virol. 1989. PMID: 2778440
-
Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.Springer Semin Immunopathol. 1993;15(2-3):275-91. doi: 10.1007/BF00201107. Springer Semin Immunopathol. 1993. PMID: 8256202 Review. No abstract available.
-
Antibody Isotypes for Tumor Immunotherapy.Transfus Med Hemother. 2017 Sep;44(5):320-326. doi: 10.1159/000479240. Epub 2017 Sep 7. Transfus Med Hemother. 2017. PMID: 29070977 Free PMC article. Review.
Cited by
-
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.Vaccine. 2012 Oct 12;30(46):6541-6550. doi: 10.1016/j.vaccine.2012.08.049. Epub 2012 Sep 1. Vaccine. 2012. PMID: 22947141 Free PMC article.
-
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.J Virol. 1993 Oct;67(10):5843-8. doi: 10.1128/JVI.67.10.5843-5848.1993. J Virol. 1993. PMID: 7690411 Free PMC article.
-
Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells.Immune Netw. 2018 Feb 20;18(1):e10. doi: 10.4110/in.2018.18.e10. eCollection 2018 Feb. Immune Netw. 2018. PMID: 29503740 Free PMC article.
-
Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.Clin Vaccine Immunol. 2012 Feb;19(2):120-7. doi: 10.1128/CVI.05355-11. Epub 2011 Dec 7. Clin Vaccine Immunol. 2012. PMID: 22155769 Free PMC article.
-
The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells.J Immunol Res. 2019 Nov 26;2019:2724078. doi: 10.1155/2019/2724078. eCollection 2019. J Immunol Res. 2019. PMID: 31886297 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous